Member Info for colbaltblue

Enormous amount of sells being managed including what looks like a 100000 earlier.

How do the mm's manage this and actually let it go blue?

I'm assuming lots of buying via DMA as mentioned previously.

Can somebody take this dog outside and shoot it. What a disgraceful mess.

It will be interesting to see what happens when the retail sells start to dry up. There's not much free float.

I don't know why anyone would sell atm unless they had to.

When I saw this header, I was just about ready to fit my "bite your hand off" teeth which I keep for desperate situations🤣

I've never seen such an appetite for shares!

The sells ( why would anyone sell?) are being absorbed by the entity building a stake.

My highly technical assessment is that it's "tin hat" time for the duration.

Until we know more about the reasons for the abandonment of the trial and who might be at fault, we should avoid the sort of nonsense talk that went on last week. The science around this trial is way above my pay grade and, with respect, probably yours.

You have to decide based on your personal circumstances one of two options. You sell and go because you see no future for Sareum or you stay and hope that things improve.

I believe that the three guys in charge want to retire rich rather than retire having seen 20 years work down the pan. That's an incentive isn't it?

Looking back at the 5year chart how have you got such a high average? (if you don't mind me asking!)

I agree. There are some miserable bu**ers posting here. Same old doomsters day after day.

I don't think they have enough evidence to comment anymore on the curtailment of the study. Reputations are on the line. I think JR said they hope to have more answers in about a week and then an update will be given.

I didn't get the impression that anything else was being hidden. They were upfront about the complexities of arranging another study.

NAV, totally agree with that.

I still think this will handsomely reward many but there's no point in pretending that the longer potential timescales aren't disappointing.

Maybe 737 will be the welcome surprise.

Did you listen in today Bill?

Billy Bunter is a holder of many shares I think. I don't know if it was him who said that, but I'm sure he would have listened to the presentation. It would be good to read his input at some stage.

In simple terms plenty of potential wins.

The tox trial starts in Jan reports in May with a successful outcome. Maybe an offer comes in before.

737 is licensed.

AI report due by Y/E Dec 25 is positive. 1802 is licensed. Cash situation is good. Maybe CRO messed up the trial so compensation paid.

Simplistic? Yes but all possible.

After that comment by Damion, I'd recommend anyone to listen to the broadcast and decide whether it really was that bad. There was certainly no squeaky chair distraction!

John sounded a bit nervous to start with but got into his stride. I thought they sounded ok as a group. They're probably feeling bruised after the trial was ended. I found the slide presentation useful tbh.

My question about financial recompense from the abandoned study didn't get asked. Earlier in the presentation, Dr Parker said he was "very confident" that 1801 was not to blame for the trial problem. New trial likely to get underway in Jan at the latest. Unable to use any data from the abandoned trial.

Very clear that they are not proceeding to P2 on 1801. Too costly and not in the business model.

In summary, I thought it was a good presentation and Tim sounded quite animated!

Obviously some concern about the CRO as reputations may be at stake but they will update when possible.

Plenty of room for a nice "blue sky" event for 737.

The market seems very happy to absorb the retail sales.

I raised that earlier but pressed enter too quickly so my post was disjointed.

I'm 100% certain that will be asked at the meeting later.

Damion, if the news had been as you expected, you would have posted at 07:01 gloating about how right you were!

I don't think you're very happy that it didn't fail.

IMO.

Study and whether a refund is expected depending on what went wrong.